| Filed On | Filing |
|---|---|
| 19 Oct 2026 |
Form 4: Dube Eric M, Director
Received 243,735 shares by exercise or conversion ($2.96M) · Sold 243,735 shares ($13.1M) |
| 17 Sep 2026 |
Form 4: Cline Christopher R., CHIEF FINANCIAL OFFICER
Received 20,000 shares by exercise or conversion ($349K) · Sold 50,508 shares ($3.15M) |
| 17 Sep 2026 |
Form 4: Inrig Jula, EVP, Head of R&D & CMO
Received 32,395 shares by exercise or conversion ($289K) · Sold 44,674 shares ($2.79M) |
| 17 Sep 2026 |
Form 4: Calvin Sandra, SVP, CHIEF ACCOUNTING OFFICER
Received 5,375 shares by exercise or conversion ($130K) · Sold 5,375 shares ($335K) |
| 17 Sep 2026 |
Form 4: Heerma Peter, EVP, CHIEF COMMERCIAL OFFICER
Received 77,190 shares by exercise or conversion ($1.41M) · Sold 102,190 shares ($6.36M) · Received 172,717 shares by exercise or conversion ($2.45M) · 3 more |
| 17 Sep 2026 |
Form 4: Dube Eric M, Director
Received 95,666 shares by exercise or conversion ($2.23M) · Sold 95,666 shares ($5.96M) · Received 195,841 shares by exercise or conversion ($4.57M) · 3 more |
| 17 Sep 2026 |
Form 4: Rote William E., Chief Research Officer
Received 78,650 shares by exercise or conversion ($1.7M) · Sold 96,198 shares ($5.99M) · Received 112,850 shares by exercise or conversion ($2.4M) · 1 more |
| 17 Sep 2026 |
Form 4: Reed Elizabeth E, Chief Legal Officer and GC
Received 37,500 shares by exercise or conversion ($580K) · Sold 37,500 shares ($2.34M) |
| 11 Sep 2026 |
Form 4: Meckler Jeffrey A, Director
Received 20,000 shares by exercise or conversion ($440K) · Sold 20,000 shares ($1.35M) |
| 03 Sep 2026 |
Form 4: Cline Christopher R., CHIEF FINANCIAL OFFICER
Sold 642 shares ($42.6K) |
| 19 Aug 2026 |
Form 4: Lyons Gary A, Director
Received 5,000 shares by exercise or conversion ($87.2K) · Sold 5,000 shares ($316K) · Received 5,000 shares by exercise or conversion ($87.2K) · 1 more |
| 22 Jun 2026 |
Form 4: Inrig Jula, CHIEF MEDICAL OFFICER
Gave 468 shares as a gift |
| 16 Jun 2026 |
Form 4: Baynes Roy D., Director
Received 4,500 shares by exercise or conversion ($96.2K) · Sold 4,500 shares ($225K) |
| 16 Jun 2026 |
Form 4: Coughlin Timothy, Director
Received 10,000 shares by exercise or conversion ($265K) · Sold 10,000 shares ($501K) |
| 21 May 2026 |
Form 4: Williams Brinkley Ruth, Director
Received 4,000 shares as a grant or award · Granted 12,000 Stock option (right to buy) |
| 21 May 2026 |
Form 4: Squarer Ron, Director
Received 4,000 shares as a grant or award · Granted 12,000 Stock option (right to buy) |
| 21 May 2026 |
Form 4: Poole Sandra, Director
Received 4,000 shares as a grant or award · Granted 12,000 Stock option (right to buy) |
| 21 May 2026 |
Form 4: Orwin John A, Director
Received 4,000 shares as a grant or award · Granted 12,000 Stock option (right to buy) |
| 21 May 2026 |
Form 4: Meckler Jeffrey A, Director
Received 4,000 shares as a grant or award · Granted 12,000 Stock option (right to buy) |
| 21 May 2026 |
Form 4: Lyons Gary A, Director
Received 4,000 shares as a grant or award · Granted 12,000 Stock option (right to buy) |
Loading...